Epicure Therapeutics, Inc.

EpiCure Therapeutics is building circuit selective adeno-associated virus (AAV) gene therapies and optimized expression systems to cure epilepsies, with an initial focus on Dravet syndrome. The venture uses its vectors to only target the brain circuit involved in the disease pathogenesis, enabling more precise and effe

Based, Epicure Therapeutics, Inc. works in advanced therapies.

Profile

EpiCure Therapeutics is building circuit selective adeno-associated virus (AAV) gene therapies and optimized expression systems to cure epilepsies, with an initial focus on Dravet syndrome. The venture uses its vectors to only target the brain circuit involved in the disease pathogenesis, enabling more precise and effective treatment. The delivery of full SCN1A gene supplementation offers […]

Within the advanced therapies space, the company focuses on its core offering rather than a broad product line.

It is recorded at the Creative Destruction Lab alumni company stage.

Website: www.epicuregtx.com